CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery solutions, is excited to announce that it’s received the BioIndustrial Innovation of the Year award by the BioTech ...

CHICAGO, January 29, 2025--(BUSINESS WIRE)--VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received ...

CHICAGO, October 16, 2024--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery solutions, announced today that its Chief Scientist, Dr. Bruce Lahn, has been honored as a PharmaVoice 100 ...

Chicago-based VectorBuilder will drop $500 million over the next four years in a two-phase project to build a new gene therapy manufacturing facility and research institute in Guangzhou, China. The ...

CHICAGO--(BUSINESS WIRE)--GSL Biotech and VectorBuilder have formed a partnership to create a complete cloning solution, allowing customers to order their entire custom plasmids directly from ...

VectorBuilder Inc. – a global leader in gene delivery solutions – has announced the construction of a new R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and ...

VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production of custom viral vectors for cell and ...

VectorBuilder Biotechnology has secured investor backing for its push to support gene delivery, raising a 410 million Chinese yuan ($57 million) series C financing round to upgrade and expand its R&D ...

VectorBuilder is a global CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) providing comprehensive, end-to-end gene delivery solutions, including ...

VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China. VectorBuilder, a global gene delivery solutions company, ...